Cargando…

A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction

AIMS: Global longitudinal strain (GLS) has become an alternative to left ventricular ejection fraction (LVEF) to determine systolic function of the heart. The absence of cut‐off values is one of the limitations preventing full clinical implementation. The aim of this study is to determine a cut‐off...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verdonschot, Job A.J., Henkens, Michiel T.H.M., Wang, Ping, Schummers, Georg, Raafs, Anne G., Krapels, Ingrid P.C., van Empel, Vanessa, Heymans, Stephane R.B., Brunner‐La Rocca, Hans‐Peter, Knackstedt, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497344/ https://www.ncbi.nlm.nih.gov/pubmed/34272829 http://dx.doi.org/10.1002/ehf2.13465

Ejemplares similares

The HFA‐PEFF and H(2)FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction
por: Sanders‐van Wijk, Sandra, et al.
Publicado: (2020)

Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry
por: Henkens, Michiel T.H.M., et al.
Publicado: (2022)

Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction
por: Barandiarán Aizpurua, Arantxa, et al.
Publicado: (2021)

Clustering of Cardiac Transcriptome Profiles Reveals Unique: Subgroups of Dilated Cardiomyopathy Patients
por: Verdonschot, Job A.J., et al.
Publicado: (2023)

Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review
por: Henkens, Michiel T.H.M., et al.
Publicado: (2020)

The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy
por: Raafs, Anne G., et al.
Publicado: (2021)

Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial
por: Hazebroek, Mark R., et al.
Publicado: (2021)

Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients
por: Raafs, Anne G., et al.
Publicado: (2022)

The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction
por: Weerts, Jerremy, et al.
Publicado: (2021)

Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal Study
por: Raafs, Anne G., et al.
Publicado: (2023)

The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles
por: Henkens, Michiel T.H.M., et al.
Publicado: (2022)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
por: Remmelzwaal, Sharon, et al.
Publicado: (2020)

Increased myocardial stiffness more than impaired relaxation function limits cardiac performance during exercise in heart failure with preserved ejection fraction: a virtual patient study
por: van Loon, Tim, et al.
Publicado: (2020)

Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction
por: Weerts, J, et al.
Publicado: (2023)

The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Weerts, Jerremy, et al.
Publicado: (2022)

A graphical analysis of aspects contributing to the spreading of measurements of left ventricular function
por: Knackstedt, Christian, et al.
Publicado: (2023)

Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction
por: Uijl, Alicia, et al.
Publicado: (2021)

Clinical Outcome in KLHL24 Cardiomyopathy
por: Vermeer, Mathilde C.S.C., et al.
Publicado: (2023)

Interatrial Block Predicts Life‐Threatening Arrhythmias in Dilated Cardiomyopathy
por: Henkens, Michiel T. H. M., et al.
Publicado: (2022)

Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences
por: Verdonschot, Job A J, et al.
Publicado: (2020)

Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
por: Dal Canto, Elisa, et al.
Publicado: (2020)

Association of left ventricular strain–volume loop characteristics with adverse events in patients with heart failure with preserved ejection fraction
por: Kerstens, Thijs P, et al.
Publicado: (2023)

Identification of sex‐specific biomarkers predicting new‐onset heart failure
por: Raafs, Anne, et al.
Publicado: (2021)

CMR-derived left ventricular intraventricular pressure gradients identify different patterns associated with prognosis in dilated cardiomyopathy
por: Vos, Jacqueline L, et al.
Publicado: (2023)

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
por: Sikking, Maurits A., et al.
Publicado: (2023)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Hemodynamic Profile of Patients With Heart Failure and Preserved Ejection Fraction Vary by Age
por: Nanayakkara, Shane, et al.
Publicado: (2017)

Association between phonocardiography and echocardiography in heart failure patients with preserved ejection fraction
por: Luo, Hongxing, et al.
Publicado: (2022)

Impaired Myocardial Oxygen Availability Contributes to Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: van Empel, Vanessa P. M., et al.
Publicado: (2014)

Impact of airflow limitation in chronic heart failure
por: Bektas, S., et al.
Publicado: (2017)

Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry
por: Uijl, A., et al.
Publicado: (2021)

Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy
por: Sikking, Maurits A., et al.
Publicado: (2023)

Allele-specific expression analysis for complex genetic phenotypes applied to a unique dilated cardiomyopathy cohort
por: van Beek, Daan, et al.
Publicado: (2023)

Unlocking the Value of White Blood Cells for Heart Failure Diagnosis
por: Meier, Stefan, et al.
Publicado: (2020)

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020)

The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

EPA 8-bunch cutting ejection
por: Krusche, A
Publicado: (1983)

Parvovirus B19 DNA detectable in hearts of patients with dilated cardiomyopathy, but absent or inactive in blood
por: Russcher, Anne, et al.
Publicado: (2021)

Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: the VIP‐HF study
por: van Veldhuisen, Dirk J., et al.
Publicado: (2020)

Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction
por: Veenis, Jesse F, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_03bqi6gk2n968jm852v28t0o1k